Red Sun Pharmaceutical: Shareholders and senior executives plan to reduce their holdings by no more than 1.57% of the shares.

RedSun Pharmaceutical announced that shareholder Yao Xiaoqing, who owns more than 5% of the company's shares, plans to reduce his holdings by no more than 46,936,300 shares within three months after fifteen trading days from the disclosure date through centralized bidding or block trading, accounting for approximately 1.5624% of the total share capital. Senior executive Chen Ruiqiang plans to reduce his holdings by no more than 169,000 shares, accounting for approximately 0.0056% of the total share capital; Zhang Kun plans to reduce his holdings by no more than 232,000 shares, accounting for approximately 0.0077% of the total share capital. The reasons for the reduction are personal fund needs, and the reduction will be carried out through centralized bidding or block trading.